Bioorganic Chemistry · 2020 · 76 citations · 36 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryMolecular OncologyDe Novo Drug DesignLigand-based DesignPotency OptimizationTyrosine Kinase InhibitorsDual-target InhibitorsEgfr InhibitionIndole ChemistryIndole DerivativesMedicinal Chemistry Applications
36
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag, Peter Hirth, James Tsai et al. · Nature · 2010 · 1.8K citations
Medicine, Oncology, Pharmacology +14
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +12
Synergistic drug combinations tend to improve therapeutically relevant selectivity
Joseph Lehár, Andrew Krueger, William Avery et al. · Nature Biotechnology · 2009 · 957 citations · Full text